Archive 1995–2023
2022, volume 38, issue 2
Original article
Pharmacotherapy administered during the intervention of emergency medical teams to people with mental disorders – a two-year observation
Łukasz Dudziński, Tomasz Kubiak
Farmakoterapia w Psychiatrii i Neurologii 2022, 38 (2), 95–106
Review article
Brexpiprazole in the treatment of schizophrenia: pharmacology, efficacy, and side effects profile
Krzysztof Bogusz, Marcin Wojnar
Farmakoterapia w Psychiatrii i Neurologii 2022, 38 (2), 107–118
Review article
Biomarkers of the central nervous system injury in Wilson’s disease
Agnieszka Antos, Tomasz Litwin, Adam Przybyłkowski, Jan Bembenek, Marta Skowrońska, Iwona Kurkowska-Jastrzębska, Łukasz Smoliński, Anna Członkowska
Farmakoterapia w Psychiatrii i Neurologii 2022, 38 (2), 119–139
Review article
Brain morphological changes in patients with diagnosis of anorexia nervosa. Nutritional rehabilitation and neuroregeneration
Paulina Gołębiowska, Katarzyna Kucharska, Dariusz Włodarek
Farmakoterapia w Psychiatrii i Neurologii 2022, 38 (2), 141–151
Review article
Cotard’s syndrome resulting from acyclovir treatment in patients with impaired renal function – literature review
Monika Nowak, Agnieszka Nowak
Farmakoterapia w Psychiatrii i Neurologii 2022, 38 (2), 153–159